News & Updates

Factors affecting survival after haematopoietic cell transplantation for myelofibrosis

29 Apr 2020

Patients with red blood cell transfusion dependence and an unfavourable molecular status suffer from worse relapse-free survival after haematopoietic cell transplantation for myelofibrosis, a recent study has shown.

Factors affecting survival after haematopoietic cell transplantation for myelofibrosis

29 Apr 2020

Phenelzine beneficial against recurrent castrate-sensitive prostate cancer

29 Apr 2020

The monoamine oxidase inhibitor phenelzine shows therapeutic potential in patients with biochemical recurrent castrate-sensitive prostate cancer, with manageable treatment-related toxicities, according to the results of a phase II trial.

Phenelzine beneficial against recurrent castrate-sensitive prostate cancer

29 Apr 2020

Fear of falling has multifactorial roots in elderly adults with cancer

29 Apr 2020

Several mental and physical factors, including cognitive status and prior falls, contribute to the fear of falling (FOF) among elderly adults with cancer, a recent study has found.

Fear of falling has multifactorial roots in elderly adults with cancer

29 Apr 2020

Leisure-time physical activity beneficial for primary cancer prevention in older adults

29 Apr 2020

Performing leisure-time physical activity (LTPA), even at lower levels than recommended, may help protect against cancer in elderly individuals, as reported in a study.

Leisure-time physical activity beneficial for primary cancer prevention in older adults

29 Apr 2020

Original New Drug Application Approvals by US FDA (16 - 30 April 2020)

29 Apr 2020

New drug applications approved by US FDA as of 16 - 30 April 2020 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 30 April 2020)

29 Apr 2020

Low-dose aspirin may reduce HCC, liver-related death risk in chronic viral hepatitis

29 Apr 2020 by

The use of low-dose aspirin was associated with a significantly lower risk of incident hepatocellular carcinoma (HCC) and liver-related mortality in patients with chronic viral hepatitis compared with no aspirin use, according to a recent Swedish study.

Low-dose aspirin may reduce HCC, liver-related death risk in chronic viral hepatitis

29 Apr 2020

Aspirin protective against digestive cancers?

28 Apr 2020 by

Regular* aspirin use may have a favourable effect on digestive** cancers, a comprehensive meta-analysis has shown.

Aspirin protective against digestive cancers?

28 Apr 2020

Polypharmacy predicts hospitalization after IV chemotherapy

28 Apr 2020

Polypharmacy in the months leading to intravenous (IV) chemotherapy appears to be correlated with hospitalization after chemotherapy, a recent study has found.

Polypharmacy predicts hospitalization after IV chemotherapy

28 Apr 2020

Adjuvant HPV vaccine could reduce CIN2+ recurrence risk

27 Apr 2020 by

Receipt of an adjuvant human papillomavirus (HPV) vaccine following surgical excision could reduce the risk of cervical intraepithelial neoplasia (CIN2+) recurrence, according to a systematic review and meta-analysis submitted for presentation at SGO 20/20.

Adjuvant HPV vaccine could reduce CIN2+ recurrence risk

27 Apr 2020

Bortezomib for maintenance, consolidation ups survival in multiple myeloma

26 Apr 2020

Bortezomib-based consolidation and maintenance therapies for multiple myeloma improve survival but come with safety concerns, reports a recent meta-analysis.

Bortezomib for maintenance, consolidation ups survival in multiple myeloma

26 Apr 2020

News & Updates

Filter by Specialty:

Specialty:

Factors affecting survival after haematopoietic cell transplantation for myelofibrosis

Factors affecting survival after haematopoietic cell transplantation for myelofibrosis

Phenelzine beneficial against recurrent castrate-sensitive prostate cancer

Phenelzine beneficial against recurrent castrate-sensitive prostate cancer

Fear of falling has multifactorial roots in elderly adults with cancer

Fear of falling has multifactorial roots in elderly adults with cancer

Leisure-time physical activity beneficial for primary cancer prevention in older adults

Leisure-time physical activity beneficial for primary cancer prevention in older adults

Original New Drug Application Approvals by US FDA (16 - 30 April 2020)

Original New Drug Application Approvals by US FDA (16 - 30 April 2020)

Low-dose aspirin may reduce HCC, liver-related death risk in chronic viral hepatitis

Low-dose aspirin may reduce HCC, liver-related death risk in chronic viral hepatitis

Aspirin protective against digestive cancers?

Aspirin protective against digestive cancers?

Polypharmacy predicts hospitalization after IV chemotherapy

Polypharmacy predicts hospitalization after IV chemotherapy

Adjuvant HPV vaccine could reduce CIN2+ recurrence risk

Adjuvant HPV vaccine could reduce CIN2+ recurrence risk

Bortezomib for maintenance, consolidation ups survival in multiple myeloma

Bortezomib for maintenance, consolidation ups survival in multiple myeloma